Skip to content
Back to clinical insights

AI in IVF 2026: Robotic Micro-Injection, Foundation Models for Viability, and the First AI-Guided…

12 March 2026 3 min read Clinician audienceBy Santaan Fertility Center and Research Institute
Clinical insight cover

AI in IVF 2026: Robotic Micro-Injection, Foundation Models for Viability, and the First AI-Guided Azoospermia Success

Clinical Disclaimer: For clinician education only; not patient-specific medical advice.

Welcome to the March 12, 2026, edition of Fertility Insights. As we move beyond the proof-of-concept phase for Artificial Intelligence in ART, today’s briefing highlights three paradigm-shifting advances that redefine the “standard of care” in high-resource laboratories: the clinical validation of Sperm Tracking and Recovery (STAR), the leap to Foundation Models (FEMI) in embryology, and the integration of robotic gripping in fertilisation.

🔬 Clinical Deep Dive: The STAR Method for Azoospermia

For decades, men with non-obstructive azoospermia (NOA) faced the trauma of invasive TESE procedures with low retrieval rates. The newly validated STAR (Sperm Tracking and Recovery) system, developed at Columbia University, has reported its first successful clinical pregnancy in a patient who struggled for 20 years.

Mechanism: The system scans approximately 8 million images per hour from a semen sample. It identifies rare, viable sperm cells invisible to the human eye, which are then isolated via microfluidic channels and retrieved by a robotic arm within milliseconds.

Evidence Level: High (First clinical pregnancy achieved; larger multicenter trials currently underway).

Clinical Impact: This allows for a non-invasive, high-speed alternative to surgical extraction, identifying sperm in samples previously categorised as “hopeless.”

Citation: “First clinical pregnancy following AI-based microfluidic sperm detection and recovery in non-obstructive azoospermia.” Columbia University / News-Medical (Oct 2025/Updated March 2026).

🤖 The Shift to Foundation Models: FEMI vs. Narrow AI

2026 marks the end of “Narrow AI” — models trained for a single lab task. The industry is moving toward Foundational IVF Models for Imaging (FEMI). Using Vision Transformer (ViT) architectures, FEMI is trained on 18 million unlabelled images through self-supervised learning.

The Breakthrough: Unlike standard grading tools, FEMI captures global context and long-range biological dependencies. It doesn’t just “score” an embryo; it segments components (ICM, TE, Zona) and predicts ploidy even in “low-quality” embryos where human grading fails.

Clinical Value: FEMI significantly outperforms ResNet and VGG architectures in predicting blastulation time and chromosomal stability.

Internal Resource: Explore Santaan’s Advanced AI-Driven Lab Technology.

Citation: “Foundation models in IVF: from speculation to implementation with FEMI.” Nature Communications (2025/2026 Update) / PMID: 41220066.

🧪 Robotic ICSI: Beyond the Human Hand

The “human variable” in fertilisation is being addressed through RoboICSI® and similar automated micromanipulation systems.

The Innovation: A robotic gripper stabilises the oocyte with calibrated finesse, while an AI-guided needle injects with micron-level accuracy. This eliminates subjective variation and reduces operator fatigue in high-volume clinics.

Performance Data: Initial data indicate a 10–15% increase in fertilisation rates and a significant reduction in oocyte degeneration compared to manual procedures.

Internal Resource: Learn about Precision IVF Protocols at Santaan.

Citation: “What Is Robotic ICSI? Enhanced Precision & Reduced Risk.” DFMC Blog / SpOvum Platform (2025/2026).

📈 Santaan’s Technical Leadership

At Santaan, we emphasize Explainability. Whether it’s follicle tracking or embryo selection, our “Human-in-the-Loop” philosophy ensures that technology serves as a precision tool for the clinician. For a deeper analysis of our 2026 technological framework, visit our specialist briefings: Santaan IVF on Medium.

Connect With Us

For Clinicians: Stay at the forefront of reproductive science. Join our collaborative network to access real-time AI-driven benchmarks and advanced diagnostic support for male-factor cases.

👉 Contact our Clinical Relations Team

https://www.google.com/search?q=https://santaan.in/contact-us

Technical Metadata

Clinical note

This brief is for clinician education and protocol discussion. It does not replace individualized patient-specific medical judgment.

Quality checks: 563 words, citation signals present, structured sections verified.

Originally authored by Santaan team and syndicated from Medium. View source